Dapaon Tablet 5mg (Dapagliflozin bis L-Proline)

Adult dose

This medication can be taken orally once daily at any time, regardless of food intake. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin have not been established in children under 18 years of age. No relevant data is available.

This drug should not be administered to certain patients. For example, it should not be given to patients with allergies to the active ingredient or excipients, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients with certain genetic lactose intolerance issues. Additionally, it should not be taken by patients undergoing dialysis. This drug should be used cautiously in patients with decreased fluid volume or impaired kidney function. It can lower blood pressure or reduce intravascular volume, which may lead to symptomatic hypotension or acute kidney injury. Special care should be taken in patients with reduced kidney function, elderly patients, and those taking diuretics to carefully evaluate fluid status and kidney function before administration, as well as monitor for signs of hypotension and changes in kidney function during administration. Adverse effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur. Women and patients with a history of infections may be at higher risk for genital infections. Diabetic ketoacidosis can occur even without high blood sugar, so if symptoms like nausea, vomiting, abdominal pain, or difficulty breathing arise, immediate medical attention is necessary. Monitoring blood ketone levels during medication use is recommended. Furthermore, this medication may have a weight loss effect, increasing the risk of decreased fluid volume and hypotension in elderly patients or those with impaired kidney function, requiring special care. Pregnant or breastfeeding women are advised not to use this drug, and if pregnancy is confirmed, administration should be discontinued. When taken in conjunction with insulin or sulfonylureas, the risk of hypoglycemia may increase, necessitating potential dose adjustments for these medications. Finally, while this drug does not significantly affect driving or operating machinery, caution is advised due to the potential for hypoglycemic symptoms.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis,

Mild side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, dry mouth, dizziness, constipation, back pain, dysuria, polyuria, nocturia, increased hematocrit, decreased initial treatment kidney creatinine clearance, dyslipidemia, increased initial treatment blood creatinine, elevated blood urea, weight loss, hives, itching, cold sweat, indigestion, nausea, diarrhea, vomiting, weakness, hunger,

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

Yellow, bilaterally convex, round film-coated tablet

Package unit

30 tablets/bottle